JCCC Research Seminar: Neil O’Brien, PhD
March 10, 2022
12:00pm – 1:00pm
Tucatinib, A Selective Small Molecule Inhibitor of HER2
Neil O’Brien, PhD
Adjunct Associate Professor, Medicine – Hematology/Oncology,
David Geffen School of Medicine at UCLA
Zoom Registration – cancer.ucla.edu/JCCCSeminarSeries
Contact – Nancy Presseau – npresseau@mednet.ucla.edu
Website – https://cancer.ucla.edu/news-events/events-calendar